Document is current
Any future updates will be listed below
-
Authors
Kang, Yoon-Koo https://orcid.org/0000-0003-0783-6583
Kim, Hyung-Don
Kim, Hyun Jin
Park, Young Soo
Beck, Mo-Youl
Ryu, Min-Hee
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 21 February 2023
First Online: 8 March 2023
Declarations
:
: Nothing directly related to this work. Out of this work, YKK has served as a consultant for ALX Oncology, Zymeworks, Amgen, Novartis, Macrogenics, Daehwa, Blueprint, Surface Oncolgy, BMS, Merck (MSD). MHR received honoraria from DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly, Ono Pharmaceutical, MSD, Taiho Pharmaceutical, Novartis, Daiichi Sankyo and AstraZeneca, and served as a consultant for DAEHWA Pharmaceutical, Bristol Myers Squibb, Lilly and Ono Pharmaceutical.
Free to read: This content has been made available to all.
